Brought to you by:
SVS Foundation seeks auction items for VAM 2022 Gala
The SVS Foundation is planning what promises to be 2022’s party of the year—and needs the help of Society for Vascular Surgery (SVS) members. The Foundation Gala is set for Friday, June 17, during the 2022 Vascular Annual Meeting (VAM)…
The top 10 most popular Vascular Specialist stories in September
Five-year data from the ACST-2 trial comparing carotid endarterectomy and carotid artery stenting, a report from the Crawford Forum at the 2021 Vascular Annual Meeting (VAM), and an Eastern Vascular Society (EVS) annual meeting piece reporting on vascular surgery as…
Study detects no difference in adverse outcomes from balloon dilatation strategy used during TCAR
Avoiding a strategy of post-stent balloon dilation during transcarotid artery revascularization (TCAR) may be unnecessary—a “contradistinction” to results shown in conventional transfemoral carotid artery stenting, new research has shown. Jones Thomas, MD, an integrated vascular surgery resident at University Hospitals…
AI and transforming vascular surgery
The 2021 Vascular Annual Meeting (VAM) Roy Greenberg Distinguished Lecture saw delegates hear about the potential for artificial intelligence (AI) to transform vascular surgery. Elsie Gyang Ross, MD, assistant professor of surgery at Stanford University, told attendees during her Aug.…
Thirty-year experience indicates SMA aneurysms are ‘relatively stable’
Based on 30 years of experience, researchers have concluded that aneurysms of the superior mesenteric artery (SMA) are “relatively stable” and that those <20mm may be safely monitored with surveillance imaging. The experience also suggests that operative treatment should be…
‘Tremendous advances in imaging possibilities’ signal further innovation, says leading vascular chief
It was a complex repair in the thoracoabdominal region of the aorta around 10 years ago, and Matthew Eagleton, MD, and his surgical team were in the process of cannulating several target vessels. They were being guided by what, for…
VAM discussion on latest paclitaxel meta-analysis yields mix of caution, skepticism
A Vascular Annual Meeting (VAM) sponsored session on paclitaxel safety drew a mix of skeptical and cautious responses to the latest meta-analysis from interventional radiologist Konstantinos Katsanos, MD, that reported a heightened risk of major amputation after use of paclitaxel-coated balloons…
Veterans with claudication who undergo revascularization ‘significantly more likely to have major amputation than those who do not’
Patients within the Veterans Affairs Administration healthcare system who underwent an intervention for intermittent claudication (IC) were consistently at three-to-four times greater risk of undergoing subsequent amputation compared to those who did not, researchers at Stanford University report. Furthermore, Intervention…
Gore Excluder IBE ‘effectively prevented common iliac artery aneurysm enlargement’
Five-year results from the U.S. prospective, multicenter study evaluating endovascular repair of iliac aneurysms using the Gore Excluder iliac branch endoprosthesis (IBE) were presented at the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM) in San Diego Thursday morning, confirming…
Dalman: Meeting challenges of COVID-19, SVS future direction head-on
In his introduction to the second of two Presidential Addresses on the 2021 Vascular Annual Meeting (VAM) slate, new Society for Vascular Surgery (SVS) President Ali AbuRahma, MD, gave voice to that which seems virtually undeniable: that the SVS presidency…